Rotavirus Vaccination in Central Europe

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F13%3A10191898" target="_blank" >RIV/00179906:_____/13:10191898 - isvavai.cz</a>
Alternative codes found
RIV/60162694:G44__/13:43874903
Result on the web
<a href="http://dx.doi.org/10.1097/MPG.0b013e31828dc35d" target="_blank" >http://dx.doi.org/10.1097/MPG.0b013e31828dc35d</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1097/MPG.0b013e31828dc35d" target="_blank" >10.1097/MPG.0b013e31828dc35d</a>

Result language
angličtina
Original language name
Rotavirus Vaccination in Central Europe
Original language description
Each year, rotavirus (RV) infection is the leading cause of acute gastroenteritis requiring hospitalisation and of nosocomially transmitted diseases in children younger than 5 years across Central European Vaccination Awareness Group (CEVAG) countries; however, inadequate surveillance systems and lack of routine RV testing still exist in most CEVAG countries, making it difficult to accurately assess the present burden of acute RV gastroenteritis in the younger population. Furthermore, routine immunisation of infants with RV vaccines has not been implemented, and no official and uniform recommendations exist in most of the countries in these territories. The present study provides CEVAG country-specific estimates of the disease burden of RV gastroenteritis among the youngest population and presents evidence-based advice on the use of RV vaccines in the region, while providing a framework for vaccination at the national level.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FN - Epidemiology, infection diseases and clinical immunology
OECD FORD branch
—

Publication year
2013
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)